Witte Amanda B, Van Arendonk Kyle, Falcone Richard A, Moody Suzanne, Hartman Heather A, Evans Emily, Thakkar Rajan, Patterson Kelli N, Minneci Peter C, Mak Grace Z, Slidell Mark B, Johnson MacKenton, Landman Matthew P, Markel Troy A, Leys Charles M, Cherney Stafford Linda, Draper Jessica, Foley David S, Downard Cynthia, Skaggs Tracy M, Lal Dave R, Ehrlich Peter F, Gourlay David
Children's Wisconsin, Medical College of Wisconsin, Milwaukee, WI, USA.
Nationwide Children's Hospital, Columbus, OH, USA.
Pediatr Surg Int. 2025 Apr 24;41(1):124. doi: 10.1007/s00383-025-06027-5.
Venous thromboembolism (VTE) is a rare but significant complication among high-risk pediatric trauma patients. The NO CLOT study's primary aim was to evaluate the safety of chemical prophylaxis against VTE in high-risk pediatric trauma patients with a secondary aim of evaluating the use of screening venous duplex ultrasound (sUS) to identify deep vein thrombosis (DVT). We hypothesized that sUS would detect asymptomatic DVT at a high rate in high-risk patients.
A prospective multi-institutional study was performed at eight level one pediatric trauma centers from 2019 to 2022. sUS was recommended 7 days after admission for all high-risk trauma patients. Univariate and multivariate analyses were performed.
Of 460 high-risk trauma patients, 64/341 (18.8%) remained admitted on day 7 and underwent sUS. Ten of 64 (15.6%) had a DVT identified on sUS (median of 6.5 [IQR 5.2, 7.0] days after trauma). In 277 patients still admitted on day 7 without sUS performed, 15 (5.4%) developed symptomatic DVT (median of 6.0 [IQR 3.0, 8.0] days after trauma. For the sUS cohort, 9/10 (90%) DVTs were associated with an indwelling central venous line (CVL) and occurred either without chemical prophylaxis use at all in 4/10 (40%) or when initiated more than 24-h post-trauma in 6/10 (60%).
In this high-risk cohort, most DVTs were identified in the first week following injury; however, the majority were asymptomatic. Use of sUS at 1-week post-injury increases DVT detection; however, the clinical consequences of asymptomatic detection of DVT remain unknown.
III.
静脉血栓栓塞症(VTE)在高危儿科创伤患者中是一种罕见但严重的并发症。“无血栓”研究的主要目的是评估高危儿科创伤患者化学预防VTE的安全性,次要目的是评估使用筛查静脉双功超声(sUS)来识别深静脉血栓形成(DVT)。我们假设sUS在高危患者中能以较高的比率检测出无症状DVT。
2019年至2022年在8个一级儿科创伤中心进行了一项前瞻性多机构研究。建议所有高危创伤患者在入院7天后进行sUS检查。进行了单因素和多因素分析。
在460例高危创伤患者中,64/341例(18.8%)在第7天仍住院并接受了sUS检查。64例中有10例(15.6%)通过sUS检查发现有DVT(创伤后中位时间为6.5天[四分位间距5.2,7.0天])。在第7天仍住院但未进行sUS检查的277例患者中,15例(5.4%)发生了有症状的DVT(创伤后中位时间为6.0天[四分位间距3.0,8.0天])。对于sUS队列,9/10例(90%)DVT与留置中心静脉导管(CVL)相关,其中4/10例(40%)完全未使用化学预防措施,6/10例(60%)在创伤后超过24小时开始使用化学预防措施。
在这个高危队列中,大多数DVT在受伤后的第一周被发现;然而,大多数是无症状的。受伤后1周使用sUS可增加DVT的检测率;然而,无症状DVT检测的临床后果仍不清楚。
III级。